Sino Biopharmaceutical Ltd. - ADR
SBHMY
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.32B
Close$
$19.32
41.6% upside
Current Fair Value
41.6% upsideUndervalued by 41.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.32 Billion |
|---|---|
| Enterprise Value | $14.61 Billion |
| Dividend Yield | $0.26 (2.22%) |
| Earnings per Share | $2.6 |
| Beta | 0.61 |
| Outstanding Shares | 902,426,200 |
Return
| Return on Equity | 7.34% |
|---|---|
| Return on Assets | 2.87% |
| Return on Invested Capital | 16.90% |
Valuation & Multiples
| P/E Ratio | 34.61 |
|---|---|
| PEG | 2549.35 |
| Price to Sales | 0.37 |
| Price to Book Ratio | 0.27 |
| Enterprise Value to Revenue | 0.43 |
| Enterprise Value to EBIT | 1.54 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 1.18 |
| Debt to Equity | 0.53 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sino Biopharmaceutical Ltd.
22,838 employees
CEO: Ping Tse Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China. It operates through three segments: Modernised Chinese Medicines and Che...